Free Trial

Organigram Q2 2024 Earnings Report

Organigram logo
C$1.82 -0.01 (-0.55%)
As of 02/21/2025 04:00 PM Eastern

Organigram EPS Results

Actual EPS
-C$0.16
Consensus EPS
-C$0.08
Beat/Miss
Missed by -C$0.08
One Year Ago EPS
N/A

Organigram Revenue Results

Actual Revenue
$37.63 million
Expected Revenue
$38.20 million
Beat/Miss
Missed by -$570.00 thousand
YoY Revenue Growth
N/A

Organigram Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Organigram Earnings Headlines

Alliance Global Partners Estimates Organigram Q3 Earnings
Q3 EPS Estimates for Organigram Reduced by Atb Cap Markets
Why Buffett and 100 members of Congress are Piling into this One Investment
This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.
See More Organigram Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Organigram? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Organigram and other key companies, straight to your email.

About Organigram

Organigram (TSE:OGI) Inc. is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.

View Organigram Profile

More Earnings Resources from MarketBeat